LHNVD-105

N/A

Report date: 2025/01/26 16:45:35

Base Information

Drug NameLHNVD-105

Drug Alias NameFlu Pep63 vaccineFlu Pep64 vaccineMulti epitope vaccine (Longhorn Vaccines & Diagnostics)Peptide vaccine (Longhorn Vaccines & Diagnostics)LHNVD-105

ClassificationBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLonghorn Vaccines and Diagnostics LLC

China Registration ClassN/A

Develop Information

Active CompaniesLonghorn Vaccines and Diagnostics LLC

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A